Mr. Campbell gave an example of regulation dealing with approval of drugs south of the border and whether we should be.... I'll give you a personal example, using the case of my mother-in-law. There was a drug in the United States that was approved and had been tested but had to wait for a clinical trial here.
Now, thank God, it saved her life—and I'm not just saying that, it actually saved her life—but it's exactly the kind of work that I think we should be doing: try to find an opportunity to work with our partners south of the border. That way, if it is tested only once and we're sure that the test is accurate, then assuring the health of Canadians, for example, can be expedited by that kind of work. I think it's a good thing we should be doing and not a bad thing.